DXCM vs SVACW · P/E 63, rev $2.50B vs $925.2M cap
DexCom Inc (DXCM) versus Spring Valley Acquisition Corp. III (SVACW) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Spring Valley Acquisition Corp. III (SVACW) common stock listed on NASDAQ.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
SVACW does not have a complete income-statement cache yet.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. SVACW currently screens at market cap $925.2M.
Not investment advice. Open the DXCM and SVACW stock pages for the full models.
Not investment advice.